Quality of life associated with sirolimus for prevention of graft-versus-host disease: results from a randomized trial.
about
Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT.Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host diseaseNew perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.
P2860
Quality of life associated with sirolimus for prevention of graft-versus-host disease: results from a randomized trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Quality of life associated wit ...... sults from a randomized trial.
@en
Quality of life associated wit ...... sults from a randomized trial.
@nl
type
label
Quality of life associated wit ...... sults from a randomized trial.
@en
Quality of life associated wit ...... sults from a randomized trial.
@nl
prefLabel
Quality of life associated wit ...... sults from a randomized trial.
@en
Quality of life associated wit ...... sults from a randomized trial.
@nl
P2860
P50
P1433
P1476
Quality of life associated wit ...... esults from a randomized trial
@en
P2093
Heather S L Jim
Joseph Pidala
P2860
P304
P356
10.3324/HAEMATOL.2013.088781
P577
2013-11-15T00:00:00Z